Semaglutide, the GLP-1 drug that Novo sells under the brand names Ozempic for diabetes and Wegovy for weight loss, has made ...

Weight loss, a possible treatment for opioid use disorder ... But it's not all positive: Last year, poison control centers ...

Analyst Michael Nedelcovych from TD Cowen maintained a Buy rating on Novo Nordisk (NVO – Research Report) and keeping the price target at ...

Analysts suggest the decline was triggered by the FDA’s rejection of its once-weekly insulin filing, coupled with a minor ...